Clinical Approach to Skin Lump
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of skin lumps
Skin lumps are one of the most common presenting complaints in primary care, accounting for approximately 10-15% of all dermatological consultations. Studies indicate that the average adult has 10-40 benign skin lesions, with lipomas alone affecting approximately 1% of the general population. While the vast majority of skin lumps are benign, the primary challenge lies in distinguishing harmless lesions from those requiring further investigation or urgent referral. Patient anxiety about potential malignancy makes thorough evaluation and clear communication essential.
Definition
A skin lump (also termed cutaneous mass, nodule, or subcutaneous swelling) is a localized area of tissue elevation that can arise from any layer of the skin or underlying structures. Lumps may originate from the epidermis, dermis, subcutaneous fat, fascia, muscle, blood vessels, lymphatic tissue, or nerves. By convention, a nodule measures 0.5-2 cm in diameter, while a tumor refers to any mass greater than 2 cm.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 2 weeks | Abscess, inflamed cyst, insect bite reaction, hematoma, acute lymphadenitis | Often inflammatory or traumatic; infection must be excluded; rapid growth warrants urgent assessment |
| Subacute | 2 weeks to 3 months | Reactive lymph node, growing cyst, foreign body granuloma, early malignancy | Persistence beyond expected resolution time raises concern; requires closer monitoring |
| Chronic | Greater than 3 months | Lipoma, epidermoid cyst, dermatofibroma, neurofibroma, sebaceous cyst | Long-standing stable lumps are usually benign; new changes in chronic lumps require investigation |
Classification by Tissue of Origin
Epidermal and Dermal Origin
Includes: Epidermoid cysts (most common), pilar cysts, dermatofibromas, keratoacanthomas, and skin cancers (basal cell carcinoma, squamous cell carcinoma, melanoma). These lesions are typically superficial, may have visible skin changes, and are often attached to the overlying skin.
Subcutaneous Origin
Includes: Lipomas (most common benign soft tissue tumor), angiolipomas, neurofibromas, and soft tissue sarcomas. These deeper lesions are typically mobile over underlying structures, covered by normal skin, and may be more difficult to characterize on examination alone.
Vascular Origin
Includes: Hemangiomas, vascular malformations, pyogenic granulomas, and angiokeratomas. These lesions often have characteristic color changes (red, blue, or purple), may be compressible, and can blanch with pressure depending on the type of vascular component.
Lymphatic and Nodal Origin
Includes: Reactive lymphadenopathy, lymphoma, metastatic carcinoma, and lymphatic malformations. Location along lymphatic drainage pathways is a key clue; associated systemic symptoms may indicate malignancy.
Classification by Physical Characteristics
| Characteristic | Description | Suggests |
|---|---|---|
| Soft and compressible | Easily deformed with gentle pressure, may have a doughy feel | Lipoma, lymphatic malformation, some cysts |
| Firm and rubbery | Resilient to pressure, springs back when released | Dermatofibroma, lymph node, neurofibroma |
| Hard and fixed | Stony consistency, immobile relative to surrounding tissue | Malignancy (primary or metastatic), calcified lesion, osteoma |
| Fluctuant | Fluid wave palpable, indicates liquid content | Abscess, cyst, ganglion, bursa |
| Pulsatile | Expansile pulsation synchronous with heartbeat | Aneurysm, arteriovenous malformation, highly vascular tumor |
Classification by Location
| Location | Common Benign Causes | Concerning Causes to Consider |
|---|---|---|
| Scalp | Pilar cyst, lipoma, dermoid cyst | Squamous cell carcinoma, metastatic deposits, cutaneous melanoma |
| Face | Epidermoid cyst, sebaceous hyperplasia, pilomatricoma | Basal cell carcinoma, squamous cell carcinoma, parotid tumor |
| Neck | Reactive lymph node, thyroglossal cyst, branchial cyst, lipoma | Lymphoma, metastatic carcinoma, thyroid malignancy |
| Trunk | Lipoma, epidermoid cyst, dermatofibroma, seborrheic keratosis | Melanoma, soft tissue sarcoma, metastatic deposits |
| Extremities | Ganglion cyst, lipoma, dermatofibroma, rheumatoid nodule | Soft tissue sarcoma, synovial cyst, giant cell tumor of tendon sheath |
| Groin and axilla | Lymph node, epidermoid cyst, hidradenitis suppurativa | Lymphoma, metastatic melanoma or carcinoma, inguinal hernia |
Key Concept — The “Rule of Three” for Skin Lumps: Three questions guide the initial assessment: (1) Is it arising from the skin or deeper structures? (2) Is it benign or potentially malignant? (3) Does it require treatment or can it be safely observed? The vast majority of skin lumps (greater than 95%) are benign, but a systematic approach ensures that the small percentage of malignant lesions are not missed.
Key Epidemiology
Most common benign lesions: Lipomas (prevalence approximately 1%), epidermoid cysts (1-2% of population), dermatofibromas, and seborrheic keratoses (extremely common in adults over 50). Malignant skin lesions: Basal cell carcinoma is the most common human malignancy, followed by squamous cell carcinoma; melanoma accounts for less than 5% of skin cancers but causes the majority of skin cancer deaths. Soft tissue sarcomas are rare (approximately 1% of adult malignancies) but must be considered in rapidly growing deep lumps.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of skin lump formation
Understanding how skin lumps form provides crucial insight into their behavior and guides clinical decision-making. Skin lumps arise through several distinct pathophysiological mechanisms, each with characteristic clinical features and implications for management. The mechanism of formation often predicts the natural history of the lesion and helps distinguish benign from malignant processes.
Fundamental Mechanisms of Lump Formation
| Mechanism | Pathophysiology | Example Conditions |
|---|---|---|
| Cystic Formation | Epithelial-lined cavity fills with fluid, keratin, or sebaceous material due to follicular obstruction or developmental inclusion | Epidermoid cyst, pilar cyst, dermoid cyst, ganglion cyst |
| Benign Proliferation | Controlled expansion of normal tissue beyond usual boundaries, with preserved cellular differentiation | Lipoma, neurofibroma, hemangioma, dermatofibroma |
| Malignant Proliferation | Uncontrolled growth with loss of normal cellular regulation, invasion of surrounding tissue, potential for metastasis | Basal cell carcinoma, squamous cell carcinoma, melanoma, sarcoma |
| Inflammatory | Accumulation of inflammatory cells and exudate in response to infection, foreign body, or autoimmune process | Abscess, infected cyst, granuloma, rheumatoid nodule |
| Lymphatic/Nodal | Reactive hyperplasia of lymphoid tissue or infiltration by malignant cells | Reactive lymphadenopathy, lymphoma, metastatic carcinoma |
Cystic Lesions — Detailed Mechanisms
Epidermoid Cyst
Mechanism: Implantation of epidermal cells into dermis (traumatic or follicular origin), forming a keratin-filled cavity lined by stratified squamous epithelium
Clinical relevance: Central punctum often visible; rupture causes intense inflammatory reaction due to keratin being highly immunogenic
Pilar (Trichilemmal) Cyst
Mechanism: Arises from outer root sheath of hair follicle; lined by epithelium without granular layer, producing dense homogeneous keratin
Clinical relevance: 90% occur on scalp; often multiple and may be familial (autosomal dominant); easier to excise intact than epidermoid cysts
Ganglion Cyst
Mechanism: Myxoid degeneration of connective tissue near joint capsule or tendon sheath, with mucin accumulation forming pseudocyst (no true epithelial lining)
Clinical relevance: Transilluminates; may fluctuate in size with activity; connected to joint or tendon sheath
Benign Proliferative Lesions — Mechanisms
| Condition | Cell of Origin | Mechanism of Growth | Clinical Implication |
|---|---|---|---|
| Lipoma | Mature adipocytes | Clonal proliferation of fat cells with chromosomal rearrangements (12q13-15 region); encapsulated by fibrous tissue; grows by expansion, not invasion | Slow growth over years; remains mobile and well-defined; malignant transformation extremely rare in superficial lipomas |
| Dermatofibroma | Dermal fibroblasts and histiocytes | Fibrous proliferation often triggered by minor trauma or insect bite; reactive proliferation of fibroblasts with collagen deposition | Characteristic dimple sign on lateral compression; stable over time; rarely exceeds 1 cm |
| Neurofibroma | Schwann cells, fibroblasts, perineural cells | Benign proliferation of nerve sheath elements; may involve mutation in NF1 gene (neurofibromin) leading to loss of tumor suppressor function | Soft, may have “buttonhole” sign; multiple lesions suggest neurofibromatosis type 1; plexiform variants have malignant potential |
| Hemangioma | Vascular endothelium | Proliferation of endothelial cells forming abnormal blood vessel networks; infantile type undergoes characteristic proliferation then involution | Compressible, may blanch; infantile hemangiomas typically resolve; adult vascular lesions are usually malformations rather than true neoplasms |
Malignant Lesions — Mechanisms of Carcinogenesis
| Condition | Key Molecular Mechanisms | Growth Pattern | Metastatic Potential |
|---|---|---|---|
| Basal Cell Carcinoma | Mutations in Hedgehog signaling pathway (PTCH1 gene most common); ultraviolet radiation-induced DNA damage | Locally invasive with very slow growth; extends peripherally and deeply; rarely metastasizes but causes significant local destruction | Less than 0.1% metastasize; local recurrence main concern |
| Squamous Cell Carcinoma | p53 mutations from cumulative ultraviolet damage; can arise from precursor actinic keratoses; immunosuppression increases risk | More aggressive than basal cell carcinoma; can grow rapidly; infiltrative margins | 2-5% metastasize; higher risk in immunosuppressed patients, lip/ear lesions, poorly differentiated tumors |
| Melanoma | BRAF mutations (50%), NRAS mutations (20%); ultraviolet radiation and genetic susceptibility (CDKN2A); disrupted cell cycle control | Radial growth phase (horizontal spread) followed by vertical growth phase (dermal invasion); early vertical growth indicates worse prognosis | High metastatic potential; breslow thickness correlates with risk; can spread to any organ |
| Soft Tissue Sarcoma | Chromosomal translocations (e.g., liposarcoma, synovial sarcoma); loss of tumor suppressor genes; often sporadic | Grows along fascial planes; pseudocapsule may give false impression of encapsulation; local recurrence common if incompletely excised | Hematogenous spread (especially to lungs); lymph node metastasis uncommon except for certain subtypes |
Inflammatory and Infectious Mechanisms
Abscess Formation
Mechanism: Bacterial infection (most commonly Staphylococcus aureus) triggers neutrophil recruitment. Accumulation of dead neutrophils, bacteria, and necrotic tissue forms pus. Fibrous wall develops as body attempts to contain infection.
Clinical relevance: Fluctuant, tender, erythematous; systemic symptoms may indicate spreading infection; requires drainage for resolution
Granulomatous Inflammation
Mechanism: Chronic inflammatory response to persistent antigen (foreign body, mycobacteria, fungus). Macrophages transform into epithelioid cells and giant cells, surrounded by lymphocytes and fibrosis.
Clinical relevance: Firm, may be associated with draining sinuses; consider tuberculosis, atypical mycobacteria, foreign body reaction
Lymph Node Enlargement — Mechanisms
| Type | Mechanism | Characteristics |
|---|---|---|
| Reactive hyperplasia | Normal immune response to local or systemic infection; expansion of lymphoid follicles and paracortical zones | Tender, mobile, rubbery; usually resolves within 2-4 weeks; often multiple nodes involved |
| Lymphoma | Malignant proliferation of lymphoid cells; Hodgkin or non-Hodgkin types with different cell of origin | Firm, rubbery, non-tender; progressive enlargement; may have constitutional symptoms (fever, night sweats, weight loss) |
| Metastatic carcinoma | Tumor cells spread via lymphatics, lodge in subcapsular sinus, proliferate and replace normal nodal architecture | Hard, fixed, non-tender; may be matted together; location suggests primary site (e.g., supraclavicular node suggests thoracic or abdominal malignancy) |
Often Overlooked Mechanism — The “Sentinel Node” Concept
A lump in a lymph node drainage basin may be the first sign of occult malignancy elsewhere. The classic example is Virchow’s node (left supraclavicular lymph node) signaling gastric or other abdominal malignancy via thoracic duct drainage. Similarly, Sister Mary Joseph nodule (periumbilical nodule) indicates intra-abdominal malignancy with umbilical lymphatic spread. Always consider what anatomical region drains to an enlarged lymph node and examine for potential primary malignancy.
Growth Rate as a Diagnostic Clue
Growth rate provides important diagnostic information:
- Very rapid (days to weeks): Inflammatory or infectious process (abscess, inflamed cyst), keratoacanthoma, or aggressive malignancy
- Moderate (weeks to months): Many malignancies including squamous cell carcinoma and melanoma; warrants urgent investigation
- Slow (months to years): Most benign lesions (lipoma, epidermoid cyst, dermatofibroma); basal cell carcinoma also grows slowly
- Stable for years then sudden change: Concerning for malignant transformation; requires urgent assessment
3. History Taking
A comprehensive approach to eliciting the skin lump history
Red Flags — Require Urgent Evaluation
- Rapid growth — Doubling in size over weeks suggests malignancy or aggressive infection
- Size greater than 5 cm — Increased risk of soft tissue sarcoma
- Deep or fixed to underlying structures — Suggests invasion beyond subcutaneous tissue
- Pain without inflammation — May indicate neural involvement or malignancy
- Ulceration or bleeding — Suggests skin cancer (basal cell carcinoma, squamous cell carcinoma, melanoma)
- Associated lymphadenopathy — May indicate metastatic spread
- Constitutional symptoms — Fever, night sweats, weight loss suggest malignancy or systemic infection
- Recurrence after previous excision — Incomplete excision or aggressive pathology
Systematic History: The “LUMP IT” Approach
Use the mnemonic “LUMP IT” to ensure comprehensive history taking for any skin lump:
- L — Location and Laterality: Where exactly is the lump? Is it single or are there multiple lumps? Any lumps elsewhere on the body?
- U — Unveiling (Onset and Discovery): When did you first notice it? How did you discover it? Was there any preceding trauma or event?
- M — Morphology and Mobility: Has the shape changed? Does it move with the skin or independently? Has the overlying skin changed color?
- P — Pace of Growth: How quickly has it grown? Has it remained stable or changed recently? Any fluctuation in size?
- I — Impact and Irritation: Is it painful, tender, or itchy? Does it interfere with function? Any discharge or bleeding?
- T — Treatments and Triggers: Have you tried any treatments? Any previous biopsies or excisions? Does anything make it better or worse?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Epidermoid cyst | Central punctum, cheesy discharge, history of inflammation | “Have you ever noticed a small dark spot in the center? Has it ever become red, swollen, or discharged any material?” |
| Lipoma | Soft, mobile, slow-growing, often multiple | “Is it soft and easy to move around? Do you have similar lumps elsewhere? Does anyone in your family have similar lumps?” |
| Abscess | Rapid onset, pain, erythema, fever | “Did this come up quickly? Is it very tender to touch? Have you had any fevers or felt unwell?” |
| Lymph node | Location in nodal basin, associated infection or systemic symptoms | “Have you had any recent infections, sore throat, or dental problems? Any unexplained fevers, night sweats, or weight loss?” |
| Skin cancer (basal cell carcinoma, squamous cell carcinoma) | Sun-exposed area, non-healing, ulceration, pearly border | “Is this in an area that gets a lot of sun? Has it ever bled or formed a scab that doesn’t heal? Have you had skin cancers before?” |
| Melanoma | Pigmented, asymmetric, changing, irregular border | “Has this mole changed in size, shape, or color? Is it different from your other moles? Does it ever bleed or itch?” |
| Soft tissue sarcoma | Deep, large (greater than 5 cm), rapidly growing, painless | “Is it deep beneath the skin? How quickly has it grown? Is it painful or completely painless?” |
| Ganglion cyst | Over joint or tendon, fluctuates with activity | “Is it near a joint or on your wrist? Does it change size depending on your activity level?” |
| Dermatofibroma | History of trauma or insect bite, dimples when pinched | “Do you remember being bitten or injured in that spot before it appeared? Does it dimple inward when you squeeze the sides?” |
Risk Factor Assessment
Skin Cancer Risk Factors
- Sun exposure history: Cumulative exposure, history of sunburns (especially blistering burns in childhood)
- Skin type: Fair skin, light eyes, red or blonde hair (Fitzpatrick types I-II)
- Personal history: Previous skin cancers, precancerous lesions (actinic keratoses)
- Family history: Melanoma in first-degree relatives, familial atypical mole syndrome
- Immunosuppression: Organ transplant recipients, HIV, immunosuppressive medications
- Tanning bed use: Significantly increases melanoma and squamous cell carcinoma risk
- Occupation: Outdoor workers, history of arsenic exposure
Soft Tissue Tumor Risk Factors
- Previous radiation therapy: Risk of radiation-induced sarcoma (typically more than 10 years post-treatment)
- Genetic syndromes: Neurofibromatosis type 1, Li-Fraumeni syndrome, familial adenomatous polyposis
- Chronic lymphedema: Risk of lymphangiosarcoma (Stewart-Treves syndrome)
- Chemical exposures: Vinyl chloride, herbicides (historical association)
- Foreign body: Rare association with chronic foreign body reaction
Relevant Past Medical and Surgical History
| History Element | Relevance | Key Questions |
|---|---|---|
| Previous skin lesions | Recurrence, new primary, or metastasis | “Have you had any skin lesions removed before? What were they? Did they come back?” |
| History of malignancy | Metastatic skin deposits possible from many primary sites | “Have you ever been diagnosed with any type of cancer?” |
| Immunosuppression | Increased skin cancer risk, atypical infections | “Do you take any medications that suppress your immune system? Have you had an organ transplant?” |
| Genetic conditions | Neurofibromatosis, Gardner syndrome, tuberous sclerosis | “Do you have any genetic conditions? Do multiple family members have similar lumps?” |
| Diabetes mellitus | Increased infection risk, poor wound healing | “Do you have diabetes? How well controlled is your blood sugar?” |
Medication and Drug History
Medications Affecting Skin Lumps
- Immunosuppressants — Increased risk of skin cancers and atypical infections (cyclosporine, tacrolimus, azathioprine)
- Anticoagulants — May cause hematomas mimicking lumps; relevant for surgical planning
- Corticosteroids — Skin atrophy, increased infection risk, poor wound healing
- Biologics — Variable effects on skin; some associated with granulomatous reactions
- BRAF inhibitors — Can cause keratoacanthomas and squamous cell carcinomas
Social History
- Sun exposure: Occupation, recreational activities, sunscreen use
- Smoking: Associated with squamous cell carcinoma of lip, poor wound healing
- Intravenous drug use: Risk of abscesses, infected injection sites
- Travel history: Tropical infections, parasitic causes (rare)
- Pet exposure: Cat scratch disease, sporotrichosis (gardeners)
- Occupation: Outdoor work, chemical exposures, trauma risk
Family History
Key Family History Elements
- Melanoma: First-degree relative with melanoma doubles risk; enquire about multiple primaries or early age of onset
- Multiple lipomas: Familial multiple lipomatosis (autosomal dominant)
- Neurofibromas: Neurofibromatosis type 1 (autosomal dominant, 50% de novo mutations)
- Multiple cancers: Li-Fraumeni syndrome (TP53 mutations) — breast cancer, sarcomas, brain tumors
- Colon polyps and cysts: Gardner syndrome (familial adenomatous polyposis variant) — epidermoid cysts, desmoid tumors, osteomas
4. Physical Examination
A systematic approach to examining skin lumps
Systematic Framework: Use the “SSCCCLET” approach for complete examination of any skin lump: Site, Size, Color, Consistency, Contour, Layer, Edge, Transillumination. Always examine the entire skin surface and palpate regional lymph nodes.
General Inspection
- Overall appearance: Does the patient appear well or unwell? Any signs of systemic illness, weight loss, or cachexia?
- Skin survey: Are there other similar lesions? Evidence of sun damage (solar lentigines, actinic keratoses)? Stigmata of genetic syndromes?
- Signs of inflammation: Erythema, warmth, or swelling around the lump suggesting infection or inflamed cyst
- Scars: Evidence of previous excisions or procedures in the area
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C) | Suggests infection (abscess, cellulitis) or systemic inflammatory process; lymphoma may cause low-grade fever |
| Heart Rate | Tachycardia | May indicate sepsis from infected lump or systemic illness from underlying malignancy |
| Blood Pressure | Hypotension | Concerning for sepsis in context of infected lump with systemic symptoms |
| Weight | Unintentional weight loss | Constitutional symptom suggesting malignancy; compare to previous documented weights |
Systematic Lump Examination — The “SSCCCLET” Approach
Site
- Document exact anatomical location using standard landmarks
- Consider what structures lie beneath (lymph node basins, major vessels, nerves)
- Note relationship to joints, tendons, and body contours
Size
- Measure in three dimensions (length × width × height) using calipers or ruler
- Document in centimeters for consistency and comparison
- Key threshold: Lumps greater than 5 cm have increased risk of being sarcoma
Color
| Color | Suggests | Examples |
|---|---|---|
| Skin-colored | Deeper lesion or normal epidermis overlying | Lipoma, deep cyst, ganglion |
| Erythematous | Inflammation, infection, or vascular lesion | Abscess, inflamed cyst, hemangioma |
| Blue or purple | Vascular lesion or deep pigment | Venous malformation, blue nevus, angiokeratoma |
| Brown or black | Melanocytic lesion or hemorrhage | Melanoma, seborrheic keratosis, thrombosed lesion |
| Pearly or translucent | Basal cell carcinoma characteristic | Nodular basal cell carcinoma |
| Yellow | Lipid content | Xanthoma, sebaceous hyperplasia, some cysts |
Consistency
| Consistency | Description | Differential Diagnosis |
|---|---|---|
| Soft | Easily compressible, doughy texture | Lipoma, lymphatic malformation |
| Firm | Resilient, springs back when pressed | Dermatofibroma, reactive lymph node, neurofibroma |
| Hard | Stony, unyielding to pressure | Malignancy, calcified lesion, osteoma |
| Fluctuant | Fluid wave transmitted on palpation | Cyst, abscess, ganglion, bursa |
| Pulsatile | Expansile pulsation synchronous with pulse | Aneurysm, arteriovenous malformation (distinguish from transmitted pulsation) |
Contour and Surface
- Smooth: Cyst, lipoma, lymph node
- Lobulated: Lipoma (especially larger ones), multinodular goiter
- Irregular: Concerning for malignancy
- Umbilicated: Central depression — molluscum contagiosum, keratoacanthoma
- Ulcerated: Malignancy (basal cell carcinoma, squamous cell carcinoma, melanoma) or infected lesion
- Central punctum: Epidermoid cyst — blackhead-like opening representing follicular origin
Layer (Depth)
| Test | Technique | Interpretation |
|---|---|---|
| Skin pinch test | Attempt to pinch skin over the lump | If skin moves freely over lump → subcutaneous; if skin tethered → intradermal or skin-attached |
| Muscle contraction test | Ask patient to tense underlying muscle | Lump becomes less mobile or fixed → deep to fascia (subfascial); remains mobile → superficial to fascia |
| Slip sign | Press edge of lump and slide finger across | Lump slips away from finger → encapsulated and mobile (lipoma, cyst) |
Edge (Margins)
- Well-defined: Can trace entire circumference — suggests benign, encapsulated lesion
- Ill-defined: Cannot clearly delineate margins — concerning for infiltrative process or malignancy
- Fixed: Attached to overlying skin or underlying structures — malignancy or chronic inflammation
- Mobile: Moves freely in all directions — benign encapsulated lesion
Transillumination
- Technique: In darkened room, place bright light source against one side of lump
- Positive (transilluminates): Light passes through — fluid-filled cyst, ganglion, hydrocele
- Negative (opaque): Light does not pass — solid mass (lipoma, tumor, lymph node)
- Note: Lipomas may partially transilluminate due to fat content; very thick-walled cysts may not transilluminate
Special Examination Signs
| Sign | Technique | Positive Finding Suggests |
|---|---|---|
| Dimple sign (Fitzpatrick sign) | Pinch skin on either side of lesion | Central dimpling occurs → dermatofibroma (tethered to dermis) |
| Buttonhole sign | Push center of soft lump | Invaginates through a defect → neurofibroma |
| Slip sign | Press and slide finger across lump edge | Lump slips away → lipoma (encapsulated, lobulated) |
| Compression blanching | Apply pressure to vascular-appearing lesion | Blanches and refills → vascular lesion (hemangioma, vascular malformation) |
| Pulsation test | Place fingers on either side, assess for expansile pulsation | Expansile (fingers pushed apart) → aneurysm; Transmitted (fingers lift together) → adjacent to artery |
| Cough impulse | Ask patient to cough while palpating | Impulse felt → hernia or vascular connection with increased intra-abdominal pressure |
Regional Lymph Node Examination
Critical Step — Always Examine Regional Lymph Nodes
For any suspicious skin lump, examination of the draining lymph node basin is mandatory. Palpable lymphadenopathy may indicate metastatic spread and significantly changes management.
| Lump Location | Lymph Node Basin to Examine | Technique |
|---|---|---|
| Scalp, face, anterior neck | Cervical chain (submental, submandibular, jugular, posterior triangle) | Examine from behind with patient’s neck slightly flexed |
| Upper limb, lateral trunk, breast | Axillary nodes (pectoral, lateral, subscapular, central, apical) | Support patient’s arm, palpate high into axilla |
| Lower limb, buttock, perineum | Inguinal nodes (superficial and deep) | Palpate along inguinal ligament and femoral triangle |
| Posterior trunk (midline) | May drain to either axilla; examine both | Bilateral axillary examination required |
Expected Findings by Etiology
| Condition | Typical Appearance | Palpation Findings | Special Features |
|---|---|---|---|
| Epidermoid cyst | Skin-colored, may have visible punctum | Firm, round, mobile, attached to skin | Central punctum; cheesy discharge if expressed; may become inflamed |
| Lipoma | Skin-colored, may have slight yellowish hue | Soft, lobulated, mobile, slip sign positive | Painless (angiolipoma is painful); may be multiple; partially transilluminates |
| Dermatofibroma | Brown, firm papule or nodule; usually less than 1 cm | Firm, tethered to dermis | Positive dimple sign; often on legs; history of insect bite |
| Ganglion cyst | Skin-colored swelling over joint or tendon | Firm, smooth, fixed to deep structures | Transilluminates; fluctuates with activity; may disappear with wrist extension |
| Abscess | Erythematous, swollen, may have pustule | Warm, tender, fluctuant | Surrounding cellulitis; patient may be febrile; pointing if superficial |
| Reactive lymph node | Skin-colored unless overlying cellulitis | Tender, firm, rubbery, mobile | In lymph node basin; often multiple; associated infection may be evident |
| Basal cell carcinoma | Pearly papule with telangiectasia; may be ulcerated | Firm, well-defined | Rolled pearly edge; sun-exposed areas; may bleed easily |
| Squamous cell carcinoma | Keratotic, indurated, may be ulcerated | Hard, irregular, may be fixed | Crusted or scaly surface; rapid growth; sun-damaged skin |
| Melanoma | Asymmetric pigmented lesion with irregular borders | May be nodular and firm or flat | Color variation; evolving; ABCDE criteria; may be amelanotic |
Important Teaching Point
Clinical examination alone cannot exclude malignancy. While certain features are reassuring (soft, mobile, well-defined margins), no physical finding definitively rules out malignancy. Any lump with concerning features (rapid growth, size greater than 5 cm, deep location, hard consistency, fixation) requires imaging or histological confirmation. The “if in doubt, cut it out” approach for smaller superficial lesions, or imaging followed by biopsy for larger or deeper lesions, is prudent clinical practice.
Dermoscopy (if available)
For pigmented lesions or suspected skin cancers, dermoscopy significantly improves diagnostic accuracy:
- Melanoma: Atypical pigment network, irregular dots/globules, regression structures, blue-white veil
- Basal cell carcinoma: Arborizing vessels, blue-gray ovoid nests, leaf-like structures, spoke wheel areas
- Seborrheic keratosis: Comedo-like openings, milia-like cysts, fissures and ridges
- Dermatofibroma: Central white scar-like patch with peripheral delicate pigment network
5. Differential Diagnosis
Systematic approach organized by probability, location, and clinical features
Epidermal and Dermal Lumps
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Seborrheic keratosis | Waxy, “stuck-on” appearance; brown; multiple in elderly; well-demarcated | Sudden appearance of multiple lesions (Leser-Trélat sign) may indicate internal malignancy |
| COMMON | Epidermoid cyst | Central punctum; firm; attached to skin; cheesy content if expressed | Rapid enlargement with pain suggests infection requiring drainage |
| COMMON | Dermatofibroma | Firm; brown; less than 1 cm; positive dimple sign; often on legs | Multiple lesions may indicate immunosuppression or systemic disease |
| LESS COMMON (approximately 20%) | Pilar cyst | Scalp location (90%); smooth; no punctum; often multiple and familial | Proliferating pilar tumor (rare malignant transformation) |
| LESS COMMON | Keratoacanthoma | Rapid growth over weeks; central keratin plug; volcano-like; may regress spontaneously | Cannot reliably distinguish from squamous cell carcinoma clinically — excise all lesions |
| UNCOMMON BUT SERIOUS (approximately 10%) | Basal cell carcinoma | Pearly papule; telangiectasia; rolled border; sun-exposed areas; may ulcerate | Local invasion can cause significant tissue destruction; rarely metastasizes |
| UNCOMMON BUT SERIOUS | Squamous cell carcinoma | Keratotic; indurated; may ulcerate; sun-damaged skin; rapid growth | Metastatic potential (2-5%); higher risk on lip, ear, immunosuppressed patients |
| UNCOMMON BUT SERIOUS | Melanoma (nodular) | Pigmented or amelanotic nodule; rapid vertical growth; may bleed | High metastatic potential; nodular melanoma may lack ABCDE features |
Subcutaneous Lumps
Step-by-Step Approach to Subcutaneous Lumps:
- Step 1: Determine if superficial (above fascia) or deep (below fascia) using muscle contraction test
- Step 2: Assess size — lumps greater than 5 cm require imaging to exclude sarcoma
- Step 3: Consider location-specific diagnoses (ganglion near joints, lymph nodes in drainage basins)
- Step 4: If deep, large, or rapidly growing — image before biopsy to avoid seeding
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Lipoma | Most common soft tissue tumor (approximately 50% of benign subcutaneous lumps) | Soft, lobulated, mobile, slip sign positive; painless; slow growth over years |
| COMMON | Reactive lymph node | Very common in context of infection | In lymph node basin; tender; rubbery; associated with identifiable infection |
| COMMON | Ganglion cyst | Most common hand and wrist mass (60-70%) | Over joint or tendon; firm; transilluminates; size fluctuates with activity |
| LESS COMMON | Angiolipoma | Approximately 5-17% of lipomas | Painful (unlike ordinary lipoma); often multiple; forearm common site |
| LESS COMMON | Neurofibroma | Solitary common; multiple suggests neurofibromatosis type 1 | Soft; buttonhole sign positive; may follow nerve distribution |
| LESS COMMON | Schwannoma | Less common than neurofibroma | Along peripheral nerve; positive Tinel sign; eccentric to nerve |
| UNCOMMON BUT SERIOUS | Soft tissue sarcoma | Approximately 1% of adult malignancies; approximately 15,000 cases per year in United States | Deep, greater than 5 cm, rapidly growing, painless; pseudocapsule gives false sense of benignity |
| UNCOMMON BUT SERIOUS | Metastatic carcinoma (subcutaneous) | Rare presenting feature | Hard, fixed; history of primary malignancy; may be multiple |
| UNCOMMON BUT SERIOUS | Lymphoma | Hodgkin and non-Hodgkin types | Rubbery lymph nodes; non-tender; progressive; constitutional symptoms (B symptoms) |
Anatomical Approach to Differential Diagnosis
Head and Neck
Epidermoid cyst
Pilar cyst (scalp)
Lipoma
Dermoid cyst (midline)
Thyroglossal cyst (midline neck)
Branchial cyst (lateral neck)
Cervical lymphadenopathy
Basal cell carcinoma (face)
Parotid tumor
Upper Limb
Ganglion cyst (wrist, hand)
Lipoma
Epidermoid cyst
Giant cell tumor of tendon sheath
Dupuytren’s nodule (palm)
Rheumatoid nodule (elbow)
Epitrochlear lymph node
Axillary lymphadenopathy
Trunk
Lipoma (most common site)
Epidermoid cyst
Seborrheic keratosis
Dermatofibroma
Melanoma
Neurofibroma
Sister Mary Joseph nodule (umbilical)
Desmoid tumor
Lower Limb and Groin
Dermatofibroma (legs common)
Lipoma
Baker’s cyst (popliteal fossa)
Inguinal lymphadenopathy
Femoral hernia
Saphena varix
Inguinal hernia
Soft tissue sarcoma (thigh common)
Inflammatory and Infectious Lumps
| Condition | Key Features | Risk Factors | Distinguishing Points |
|---|---|---|---|
| Abscess | Tender, erythematous, fluctuant; may have pointing or discharge | Diabetes, immunosuppression, intravenous drug use, recent skin breach | Rapid onset (days); systemic symptoms if severe; requires drainage |
| Inflamed epidermoid cyst | Previously stable cyst now tender, red, enlarged | Trauma to cyst, attempted expression | History of pre-existing lump; sterile inflammation from rupture or secondary infection |
| Hidradenitis suppurativa | Recurrent abscesses in axillae, groin, inframammary | Obesity, smoking, family history | Chronic relapsing course; sinus tracts; scarring; apocrine gland distribution |
| Pilonidal cyst/abscess | Natal cleft location; may have visible pits or hair | Male, hirsute, sedentary occupation | Midline sacrococcygeal location; recurrence common |
| Granuloma (foreign body) | Firm nodule at site of previous injury or injection | Trauma, surgery, injection (filler, vaccine) | History of foreign material introduction; may have draining sinus |
| Mycobacterial infection | Chronic draining nodule; violaceous; indolent | Immunosuppression, fish tank exposure (Mycobacterium marinum) | Poor response to standard antibiotics; sporotrichoid spread pattern |
Vascular Lumps
| Condition | Appearance | Palpation | Key Features |
|---|---|---|---|
| Cherry angioma | Bright red papule, 1-5 mm | Soft, may blanch | Extremely common in adults; benign; no treatment needed unless cosmetic concern |
| Pyogenic granuloma | Red, friable, bleeds easily; rapid growth | Soft, often pedunculated | Often follows minor trauma; pregnancy; medications (retinoids, EGFR inhibitors) |
| Venous malformation | Blue-purple, compressible | Soft, empties with elevation, fills with dependency | Present from birth (may not be noticed); enlarges over time; may have phleboliths |
| Arteriovenous malformation | Warm, may have visible pulsation | Pulsatile, thrill may be present | Bruit on auscultation; may cause cardiac symptoms if large |
| Kaposi sarcoma | Purple-red nodules or plaques; may be multiple | Firm, non-blanching | HIV/AIDS associated (most common); also occurs in elderly and transplant patients |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Soft, lobulated, mobile, slip sign positive | Lipoma | Reassure if small and superficial; image if greater than 5 cm or deep |
| Firm nodule with central punctum | Epidermoid cyst | Excision if symptomatic; avoid incision and drainage unless infected |
| Brown papule on leg, positive dimple sign | Dermatofibroma | Reassurance; excision only if diagnostic uncertainty or patient preference |
| Pearly nodule with telangiectasia on face | Basal cell carcinoma | Biopsy to confirm; referral for surgical excision or other treatment |
| Rapidly growing keratotic nodule on sun-damaged skin | Squamous cell carcinoma or keratoacanthoma | Excision biopsy; cannot distinguish clinically — treat as malignant |
| Changing pigmented lesion | Melanoma until proven otherwise | Urgent excision biopsy with appropriate margins |
| Deep lump greater than 5 cm, rapidly growing | Soft tissue sarcoma | MRI before biopsy; refer to sarcoma specialist center |
| Firm, rubbery, non-tender lymph node enlarging over weeks | Lymphoma or metastatic carcinoma | Excision biopsy (not fine needle aspiration) for lymphoma workup |
| Lump over dorsal wrist that transilluminates | Ganglion cyst | Reassurance; aspiration if symptomatic; surgical excision for recurrence |
| Multiple soft lumps, family history | Familial multiple lipomatosis or neurofibromatosis | Examine for other features; genetic counseling if indicated |
Diagnostic Mimics — Don’t Miss These
- Amelanotic melanoma: Pink or red nodule lacking pigment; often misdiagnosed as pyogenic granuloma or basal cell carcinoma
- Merkel cell carcinoma: Rapidly growing, violaceous nodule in elderly; highly aggressive; often on head and neck
- Dermatofibrosarcoma protuberans: Slow-growing dermal tumor; may resemble keloid or dermatofibroma; locally aggressive
- Cutaneous metastases: May mimic benign cysts or lipomas; consider in patients with known malignancy
- Atypical lipomatous tumor: Large, deep lipoma-like mass; represents well-differentiated liposarcoma; requires complete excision
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Key Principle: Many skin lumps can be diagnosed clinically and require no investigations. Investigation is indicated when: (1) the diagnosis is uncertain, (2) malignancy is suspected, (3) the lesion is deep or large, or (4) surgical planning requires anatomical detail. The choice of investigation depends on the clinical question being asked.
Indications for Investigation
| Clinical Scenario | Investigation Required? | Rationale |
|---|---|---|
| Classic lipoma (soft, mobile, less than 5 cm, superficial) | No — clinical diagnosis sufficient | Characteristic features allow confident diagnosis; excise if symptomatic |
| Epidermoid cyst with visible punctum | No — clinical diagnosis sufficient | Pathognomonic features; excise if symptomatic; histology confirms |
| Suspected skin cancer (basal cell carcinoma, squamous cell carcinoma) | Yes — biopsy before or at time of excision | Histological confirmation guides treatment and prognosis |
| Pigmented lesion suspicious for melanoma | Yes — excision biopsy (not punch or shave) | Full-thickness excision allows accurate Breslow depth measurement |
| Lump greater than 5 cm or deep to fascia | Yes — MRI before biopsy | Rule out sarcoma; imaging defines extent and guides biopsy approach |
| Lymph node enlargement persisting more than 4-6 weeks | Yes — bloods, imaging, consider biopsy | Exclude lymphoma or metastatic disease |
Laboratory Investigations
| Investigation | When to Order | What to Look For | Practical Points |
|---|---|---|---|
| Full blood count | Suspected infection, lymphoma, systemic illness | Leukocytosis (infection); lymphocytosis or cytopenias (lymphoma); anemia (chronic disease) | Non-specific but useful baseline; guides urgency |
| Inflammatory markers (C-reactive protein, erythrocyte sedimentation rate) | Suspected abscess, inflammatory condition | Elevated in infection; very high erythrocyte sedimentation rate may suggest malignancy or vasculitis | C-reactive protein more responsive to acute changes |
| Lactate dehydrogenase | Suspected lymphoma | Elevated in high-grade lymphoma; prognostic marker | Non-specific; elevated in many conditions |
| Blood glucose or HbA1c | Recurrent infections, poor wound healing | Undiagnosed or poorly controlled diabetes | Important for surgical planning and infection risk assessment |
| HIV serology | Kaposi sarcoma, atypical infections, unexplained lymphadenopathy | HIV infection | Offer with appropriate counseling; may explain unusual presentations |
| Protein electrophoresis | Suspected myeloma (plasmacytoma), amyloidosis | Monoclonal protein (M-spike) | Consider in elderly with unexplained soft tissue mass or pathological fracture |
Imaging Investigations
Ultrasound
Indications
- First-line imaging for superficial soft tissue lumps
- Distinguishing solid from cystic lesions
- Assessing lymph node architecture
- Guiding fine needle aspiration or core biopsy
- Evaluating vascular lesions with Doppler
Typical Findings
- Lipoma: Homogeneous, hyperechoic, compressible, parallel to skin
- Epidermoid cyst: Well-defined, hypoechoic, posterior acoustic enhancement
- Lymph node: Oval, hilar vascularity (reactive); round, loss of hilum (suspicious)
- Abscess: Hypoechoic collection with debris, surrounding hyperemia
MRI (Magnetic Resonance Imaging)
Indications
- Mandatory for deep lumps greater than 5 cm (sarcoma workup)
- Lesions deep to fascia or involving muscle
- Preoperative planning for complex excisions
- Assessing relationship to neurovascular structures
- Evaluating extent of large or infiltrative lesions
Key Points
- MRI should be performed before biopsy to avoid post-procedure changes
- Lipomas appear hyperintense on T1-weighted images (follow fat signal)
- Most sarcomas are heterogeneous with areas of necrosis
- MRI cannot definitively distinguish benign from malignant — biopsy still needed
CT (Computed Tomography)
| Indication | Advantages | Limitations |
|---|---|---|
| Staging for malignancy (chest, abdomen, pelvis) | Fast; good for detecting pulmonary metastases; wide availability | Ionizing radiation; inferior soft tissue contrast compared to MRI |
| Evaluating bony involvement | Superior bone detail compared to MRI | May miss early marrow involvement |
| CT-guided biopsy of deep lesions | Real-time guidance for difficult locations | Radiation exposure; may not be needed if ultrasound accessible |
Biopsy Techniques
Critical Principle — Biopsy Planning
For suspected soft tissue sarcoma, biopsy must be planned to allow subsequent wide excision. The biopsy tract will be excised with the tumor. Poorly placed biopsies can compromise limb salvage surgery. When sarcoma is suspected, refer to a specialist sarcoma center for biopsy.
| Biopsy Type | Technique | Indications | Limitations |
|---|---|---|---|
| Fine needle aspiration cytology | 22-25 gauge needle; aspirate cells for cytological examination | Lymph nodes (reactive vs metastatic); thyroid nodules; confirmation of recurrence | Cannot diagnose lymphoma (need architecture); may miss diagnosis in heterogeneous tumors |
| Core needle biopsy | 14-18 gauge cutting needle; obtains tissue core for histology | Deep soft tissue masses; suspected sarcoma; lymphoma workup | Requires imaging guidance for deep lesions; sampling error possible |
| Punch biopsy | Circular blade (2-8 mm) removes full-thickness skin core | Inflammatory skin conditions; suspected dermal tumors | Not appropriate for melanoma (may not include deepest portion) |
| Shave biopsy | Tangential removal of superficial lesion | Seborrheic keratosis; suspected basal cell carcinoma; superficial lesions | Contraindicated for suspected melanoma (cannot measure Breslow depth) |
| Incisional biopsy | Surgical removal of representative portion of lesion | Large lesions where excision not immediately possible; sarcoma (specialist setting) | Requires surgical expertise; biopsy tract must be excisable |
| Excisional biopsy | Complete surgical removal of lesion | Small lesions; suspected melanoma (with 2 mm margins); lymph node for lymphoma | May compromise subsequent wider excision if margins insufficient for malignancy |
Diagnostic Pathways by Clinical Scenario
Suspected Skin Cancer (Basal Cell Carcinoma or Squamous Cell Carcinoma)
First-Line
- Dermoscopy: Improves diagnostic accuracy; can be performed in primary care with training
- Punch or shave biopsy: If diagnosis uncertain or to confirm before treatment
Further Investigations
- Imaging: Usually not required for basal cell carcinoma; consider for high-risk squamous cell carcinoma (CT for nodal staging)
- Sentinel lymph node biopsy: Not routine; may be considered for very high-risk squamous cell carcinoma
Suspected Melanoma
Melanoma Investigation Pathway
- Excision biopsy: Complete excision with 2 mm clinical margins; do NOT perform shave or punch biopsy
- Histopathology: Breslow thickness, ulceration, mitotic rate, microsatellitosis determine staging and prognosis
- Sentinel lymph node biopsy: Recommended for melanomas greater than 1 mm Breslow thickness (or greater than 0.8 mm with high-risk features)
- CT or PET-CT staging: For thick melanomas (greater than 4 mm), positive sentinel node, or clinical evidence of metastasis
- BRAF mutation testing: For stage III and IV melanoma to guide systemic therapy
Suspected Soft Tissue Sarcoma
Sarcoma Investigation Pathway (refer to specialist center):
- MRI of primary site: Before any biopsy; defines extent and relationship to structures
- Core needle biopsy: Performed by or in consultation with sarcoma surgeon; longitudinal orientation along planned incision
- CT chest: Staging for pulmonary metastases (most common site of spread)
- CT abdomen and pelvis: For retroperitoneal or pelvic tumors
- PET-CT: May be useful for staging high-grade sarcomas
Lymphadenopathy Workup
| Step | Investigation | Purpose |
|---|---|---|
| 1 | Full blood count, blood film, lactate dehydrogenase | Screen for hematological malignancy; cytopenias, abnormal cells |
| 2 | Ultrasound of lymph node | Assess architecture; guide biopsy if needed |
| 3 | Serological tests (EBV, CMV, HIV, toxoplasma) | Identify infectious causes of reactive lymphadenopathy |
| 4 | Core biopsy or excision biopsy | Histological diagnosis; excision preferred if lymphoma suspected (architecture needed) |
| 5 | CT neck, chest, abdomen, pelvis | Staging if malignancy confirmed |
Dermoscopy — Key Diagnostic Features
| Lesion | Dermoscopic Features | Clinical Significance |
|---|---|---|
| Seborrheic keratosis | Comedo-like openings (crypts), milia-like cysts, fissures, brain-like pattern | Benign; no biopsy needed if classic features present |
| Dermatofibroma | Central white scar-like patch, peripheral delicate pigment network | Benign; reassurance; correlate with positive dimple sign |
| Basal cell carcinoma | Arborizing (branching) vessels, blue-gray ovoid nests, leaf-like structures, spoke wheel areas, ulceration | Malignant but locally invasive; biopsy and excision |
| Squamous cell carcinoma | Central keratin (yellow-white), hairpin or glomerular vessels, white circles | Malignant with metastatic potential; biopsy and excision |
| Melanoma | Atypical pigment network, irregular streaks, blue-white veil, regression structures, atypical dots and globules, polymorphous vessels | High metastatic potential; urgent excision biopsy |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for skin lumps
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Rapidly enlarging pigmented lesion with bleeding | EMERGENT | Urgent referral to dermatology or plastic surgery within 2 weeks; excision biopsy |
| Deep lump greater than 5 cm, rapidly growing | EMERGENT | Urgent MRI and referral to sarcoma center; do not biopsy in primary care |
| Fluctuant, tender lump with fever and systemic symptoms | EMERGENT | Incision and drainage; antibiotics; consider hospital admission if septic |
| Hard, fixed lymph node with weight loss and night sweats | EMERGENT | Urgent blood tests and imaging; expedited biopsy; 2-week wait referral |
| Pearly nodule with telangiectasia on face (suspected basal cell carcinoma) | URGENT | Referral to dermatology within 2-4 weeks; biopsy to confirm |
| Keratotic, indurated nodule on sun-damaged skin (suspected squamous cell carcinoma) | URGENT | Urgent referral within 2 weeks; biopsy and excision |
| Persistent lymph node more than 4 weeks without clear cause | URGENT | Blood tests, ultrasound; consider biopsy if no resolution in 6 weeks |
| Soft, mobile, stable lump present for years (likely lipoma) | ROUTINE | Clinical diagnosis; reassurance; elective excision if symptomatic |
| Firm nodule with central punctum (epidermoid cyst) | ROUTINE | Clinical diagnosis; elective excision if bothersome; avoid incision and drainage unless infected |
| Small brown papule on leg, dimple sign positive (dermatofibroma) | ROUTINE | Reassurance; no treatment required; excision only for cosmesis or diagnostic uncertainty |
Step 2: Classify the Lump
By Depth
Epidermal/Dermal: Attached to skin, moves with skin pinch → likely cyst, dermatofibroma, skin cancer
Subcutaneous: Skin moves over it, above fascia → likely lipoma, epidermoid cyst
Deep (subfascial): Less mobile with muscle contraction → requires imaging to exclude sarcoma
By Size
Less than 5 cm: Most benign; clinical assessment may be sufficient
Greater than 5 cm: “Red flag” size — MRI required before biopsy to exclude sarcoma
Rapidly enlarging: Regardless of size, requires urgent assessment
By Consistency
Soft: Lipoma, lymphatic malformation
Firm: Cyst, dermatofibroma, lymph node
Hard: Concerning for malignancy — investigate
Fluctuant: Cyst, abscess, ganglion
Step 3: Follow the Decision Algorithm
Algorithm A: Superficial Lump (Epidermal/Dermal)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Waxy, stuck-on appearance, brown, elderly patient | Seborrheic keratosis | Reassurance; no treatment unless cosmetic concern; cryotherapy or curettage if desired |
| Firm nodule with visible central punctum | Epidermoid cyst | Elective excision if symptomatic; include punctum in excision; avoid incision and drainage |
| Firm brown papule, positive dimple sign, leg | Dermatofibroma | Reassurance; no treatment required |
| Pearly papule, telangiectasia, sun-exposed area | Basal cell carcinoma | Biopsy to confirm; surgical excision, Mohs surgery, or other treatment modality |
| Keratotic nodule, rapid growth, sun-damaged skin | Squamous cell carcinoma or keratoacanthoma | Excision biopsy; treat both as malignant (cannot distinguish clinically) |
| Pigmented lesion meeting ABCDE criteria or changing | Melanoma | Urgent excision biopsy with 2 mm margins; do NOT shave or punch biopsy |
Algorithm B: Subcutaneous Lump (Above Fascia)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Soft, lobulated, mobile, slip sign positive, less than 5 cm | Lipoma | Clinical diagnosis sufficient; reassurance; elective excision if symptomatic |
| Soft, lobulated but greater than 5 cm or deep component | Lipoma vs atypical lipomatous tumor | MRI to characterize; excision with histology; consider sarcoma center referral |
| Painful subcutaneous nodule, often multiple, forearm | Angiolipoma | Excision if troublesome; histology confirms vascular component |
| Soft nodule, buttonhole sign positive | Neurofibroma | Examine for café-au-lait spots and other neurofibromatosis features; genetics referral if multiple |
| Firm, over wrist or tendon, transilluminates | Ganglion cyst | Reassurance (may resolve spontaneously); aspiration if symptomatic; surgical excision for recurrence |
| Tender, erythematous, fluctuant, acute onset | Abscess | Incision and drainage; wound packing; antibiotics if cellulitis or systemic symptoms |
Algorithm C: Deep Lump (Below Fascia) or Greater Than 5 cm
Sarcoma Pathway — Do Not Biopsy in Primary Care
- Clinical suspicion: Deep location, size greater than 5 cm, rapidly growing, painless
- MRI before biopsy: Characterizes lesion; defines relationship to neurovascular structures
- Refer to sarcoma center: Biopsy must be planned by operating surgeon
- Core needle biopsy: Performed in longitudinal orientation along planned incision
- Staging CT chest: Sarcomas metastasize hematogenously to lungs
- Multidisciplinary team discussion: Surgery, oncology, radiology, pathology
Algorithm D: Lymph Node Enlargement
| Clinical Scenario | Likely Diagnosis | Action |
|---|---|---|
| Tender, mobile, associated with obvious infection | Reactive lymphadenopathy | Treat underlying infection; reassess in 2-4 weeks; should resolve |
| Persistent more than 4-6 weeks, no clear cause | Requires investigation | Blood tests (full blood count, lactate dehydrogenase, inflammatory markers); ultrasound; consider biopsy |
| Firm, rubbery, non-tender, progressive, constitutional symptoms | Lymphoma | Excision biopsy (not fine needle aspiration — architecture needed); urgent hematology referral |
| Hard, fixed, non-tender, known primary malignancy | Metastatic carcinoma | Staging imaging; fine needle aspiration or core biopsy may confirm; oncology referral |
| Supraclavicular node (especially left — Virchow’s node) | Thoracic or abdominal malignancy | Urgent CT chest, abdomen, pelvis; expedited biopsy; 2-week wait referral |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient requests removal of “lipoma” that is greater than 5 cm | Do not excise in primary care | Arrange MRI first; refer to surgical team or sarcoma center for assessment |
| Epidermoid cyst becomes acutely infected | Incision and drainage if pointing and fluctuant | Antibiotics if surrounding cellulitis; delayed excision (6-8 weeks) after inflammation settles |
| Patient has changing mole but refuses excision | Document detailed discussion of melanoma risk | Provide written information; offer second opinion; arrange close follow-up; document refusal clearly |
| Histology of “lipoma” returns as atypical lipomatous tumor | Explain this represents well-differentiated liposarcoma | Refer to sarcoma center for consideration of wider excision; MDT discussion |
| Basal cell carcinoma recurs after previous excision | Re-biopsy to confirm recurrence | Refer for Mohs micrographic surgery or specialist plastic surgery excision |
| Multiple neurofibromas in young patient | Full skin examination; check for café-au-lait spots, Lisch nodules | If neurofibromatosis type 1 criteria met, refer to genetics and neurology; annual surveillance |
| Biopsy of lymph node shows “reactive” but clinical concern remains | Consider sampling error or incorrect diagnosis | Repeat biopsy (excision rather than core); multidisciplinary discussion; close follow-up |
| Patient with transplant and multiple skin lesions | High risk of skin cancers (squamous cell carcinoma especially) | Low threshold for biopsy; dermatology surveillance; patient education on sun protection |
When to Refer
Urgent Referral (2-Week Wait)
- Suspected melanoma (changing pigmented lesion)
- Suspected squamous cell carcinoma
- Deep lump greater than 5 cm (sarcoma pathway)
- Hard, fixed lymph node with no obvious cause
- Supraclavicular lymphadenopathy
- Constitutional symptoms with lymphadenopathy
Routine Referral
- Suspected basal cell carcinoma (slow-growing, low metastatic risk)
- Lipoma for elective excision if patient preference
- Recurrent cysts requiring excision
- Ganglion cyst for surgical excision after failed aspiration
- Diagnostic uncertainty requiring specialist opinion
- Multiple neurofibromas for genetics evaluation
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The 5 cm rule: Any lump greater than 5 cm or deep to the fascia requires MRI before biopsy. This single rule prevents most missed sarcomas.
Lipomas feel like lipomas: The classic soft, lobulated, mobile lump with a positive slip sign is almost always benign. Trust your clinical findings for small, superficial, typical lipomas.
The punctum is pathognomonic: A central punctum (blackhead-like opening) on a skin lump is virtually diagnostic of an epidermoid cyst. Look carefully — it may be subtle.
Dermatofibromas dimple: The positive dimple sign (central indentation when skin is pinched laterally) is highly specific for dermatofibroma. This finding allows confident reassurance.
Transillumination tells all: A lesion that clearly transilluminates is cystic. Ganglion cysts transilluminate brightly; lipomas may glow faintly. Solid tumors do not transilluminate.
Location predicts pathology: Pilar cysts occur on the scalp (90%). Ganglions occur near joints. Dermatofibromas favor the legs. Use anatomical location to narrow the differential.
Check the draining nodes: For any suspicious skin lesion, always examine the regional lymph node basin. Palpable lymphadenopathy changes staging and management.
Sun damage is a field defect: One skin cancer means high risk of more. Patients with basal cell carcinoma or squamous cell carcinoma need full skin surveillance and sun protection counseling.
Critical Pitfalls to Avoid
Never shave biopsy a suspected melanoma: Shave biopsy prevents accurate Breslow depth measurement, which is essential for staging and prognosis. Always perform excision biopsy with 2 mm margins.
Do not biopsy deep lumps greater than 5 cm in primary care: Poorly placed biopsy tracts can compromise limb salvage surgery for sarcoma. Refer to a specialist center where the operating surgeon plans the biopsy.
Avoid incision and drainage of uninfected epidermoid cysts: Incision and drainage does not remove the cyst wall and guarantees recurrence. Only drain if actively infected; schedule formal excision later.
Do not assume all lipomas are benign: Atypical lipomatous tumor (well-differentiated liposarcoma) can mimic benign lipoma. Large (greater than 5 cm), deep, or rapidly growing “lipomas” require imaging and histology.
Never ignore the supraclavicular node: A palpable left supraclavicular node (Virchow’s node) may be the first sign of gastric, pancreatic, or other thoracic/abdominal malignancy. This requires urgent investigation.
Do not rely on fine needle aspiration for lymphoma diagnosis: Lymphoma diagnosis requires tissue architecture. Fine needle aspiration may miss the diagnosis or misclassify the subtype. Excision biopsy is preferred.
Beware the “seborrheic keratosis” that bleeds or grows: Melanoma can mimic seborrheic keratosis. If a presumed seborrheic keratosis is changing, bleeding, or atypical, biopsy it.
Do not dismiss painless lumps as benign: Many malignant soft tissue tumors are painless. Pain is not a reliable discriminator between benign and malignant lesions.
Key Takeaways
- The vast majority (greater than 95%) of skin lumps are benign, but a systematic approach ensures the few malignant lesions are not missed.
- History and examination can confidently diagnose many common lesions: lipoma (soft, mobile, slip sign), epidermoid cyst (punctum), dermatofibroma (dimple sign), ganglion (transilluminates).
- The “Rule of Three” guides initial assessment: Is it from skin or deeper? Is it benign or malignant? Does it need treatment or observation?
- Red flags requiring urgent action include: size greater than 5 cm, deep location, rapid growth, fixation, ulceration, and associated lymphadenopathy.
- For suspected skin cancer, biopsy before definitive treatment; for suspected sarcoma, image before biopsy.
- Melanoma requires excision biopsy — never shave or punch biopsy a pigmented lesion suspicious for melanoma.
- Deep lumps greater than 5 cm must have MRI before biopsy and should be referred to a sarcoma specialist center.
- Always examine regional lymph nodes for any suspicious skin lesion — nodal involvement changes staging and prognosis.
- Immunosuppressed patients (transplant recipients, HIV) have markedly increased skin cancer risk and require heightened surveillance.
- When in doubt, biopsy — histological diagnosis resolves uncertainty and guides appropriate management.
Quick Reference Algorithm
Systematic Approach to Any Skin Lump:
- Identify red flags: Size greater than 5 cm? Deep? Rapidly growing? Fixed? Ulcerated? Associated lymphadenopathy? → If yes, urgent investigation
- Determine the layer: Epidermal/dermal (attached to skin), subcutaneous (above fascia), or deep (below fascia) using skin pinch and muscle contraction tests
- Characterize the lump: Use “SSCCCLET” — Site, Size, Color, Consistency, Contour, Layer, Edge, Transillumination
- Look for diagnostic signs: Central punctum (cyst), slip sign (lipoma), dimple sign (dermatofibroma), transillumination (ganglion)
- Check regional lymph nodes: Palpable nodes may indicate infection, inflammation, or metastasis
- Decide on investigation: Clinical diagnosis sufficient? Ultrasound for characterization? MRI for deep or large lesions? Biopsy for histology?
- Determine urgency: Emergent (suspected melanoma, sarcoma, sepsis), urgent (non-melanoma skin cancer, persistent lymph node), or routine (benign lesions for elective excision)
- Arrange appropriate referral or management: Primary care excision for simple lesions; specialist referral for suspected malignancy or complex cases
Special Considerations
| Population | Key Considerations | Practical Approach |
|---|---|---|
| Immunosuppressed patients | Markedly increased risk of squamous cell carcinoma (65-250 times), basal cell carcinoma (10 times), melanoma (3-4 times) | Low threshold for biopsy; regular dermatology surveillance; aggressive sun protection |
| Patients with neurofibromatosis type 1 | Multiple neurofibromas; risk of malignant peripheral nerve sheath tumor (8-13% lifetime risk) | Annual surveillance; any rapidly growing or painful neurofibroma requires urgent imaging and biopsy |
| Patients with history of melanoma | Increased risk of second primary melanoma (5-8% at 5 years) | Total body skin examination; patient education on self-examination; photograph moles for comparison |
| Elderly patients | Higher incidence of skin cancers; may have multiple lesions; comorbidities affect treatment decisions | Consider patient wishes and life expectancy; basal cell carcinoma in elderly may be appropriate for observation if asymptomatic |